From a new way to treat diabetes via an old tuberculosis vaccine to the impact on the industry of increasing patient volumes, each week we highlight the latest in life sciences. … READ MORE >
biopharma
5 things to know in life sciences: Week of June 7
From the new Alzheimer’s drug, aducanumab, to a White House report on supply chain risk, we highlight the latest impacting the life sciences industry. … READ MORE >
5 things to know in life sciences: Week of May 31
From a new clinical trial service launched by CVS to sequencing the entire human genome, we highlight the latest trends impacting the life sciences industry this week. … READ MORE >
5 things to know in life sciences: Week of May 24
This week we highlight the 340B drug pricing program, oncology clinical trials, balancing patient privacy concerns with data needs for artificial intelligence and more. … READ MORE >
5 things to know in life sciences: Week of May 17
This week we highlight a new report on COVID-19 trials and diversity; functional service providers; biopharma, drug pricing and ESG scores; and more. … READ MORE >
5 things to know in life sciences: Week of May 10
This week we highlight small-company drug launches during the pandemic, the future of the biopharma office, using artificial intelligence to diagnose rare diseases and more. … READ MORE >
5 things to know in life sciences: Week of May 3
This week we highlight herd immunity challenges, concerns about waiving patent protections on COVID-19 vaccines, using machine learning to reduce trial risks and more. … READ MORE >
5 things to know in life sciences: Week of April 26
This week we highlight why people may be skipping their second COVID-19 dose, challenges of AI in patient diagnosis, the evolution of the regulatory environment for biopharma companies and more. … READ MORE >
5 things to know in life sciences: Week of March 29
From biopharma merger scrutiny to AI-powered biology research, we highlight what’s happening in the life sciences industry this week. … READ MORE >